Novadaq Tech price target raised to $12 from $8.50 at JMP Securities After attending Novadaq's Analyst Day, JMP Securities believes that surgeons across a wide variety of indications continue to support the technology, The firm thinks the company's devices are transformative, and that the company has a multi-billion dollar market opportunity. The firm maintains an Outperform rating on the shares.
News For NVDQ From The Last 14 Days
Check below for free stories on NVDQ the last two weeks.